{
    "pmcid": "10968798",
    "qa_pairs": {
        "How do nanobodies maintain stability under extreme conditions?": [
            "They have melting temperatures around 67\u00b0C.",
            "They are resistant to enzymatic degradation.",
            "They have a rigid tertiary structure that prevents denaturation.",
            "They are encapsulated in lipid nanoparticles."
        ],
        "In what form can nanobodies be engineered to enhance their neutralizing potency against SARS-CoV-2?": [
            "Multivalent forms such as dimers or trimers.",
            "Single-chain forms with increased hydrophobicity.",
            "Monovalent forms with increased charge.",
            "Encapsulated forms in liposomes."
        ],
        "What is a potential future direction for nanobody research in SARS-CoV-2 applications?": [
            "Integrating nanobodies with advanced technologies like microfluidics and nanotechnology.",
            "Developing nanobodies that can be administered orally.",
            "Using nanobodies to target intracellular viral components.",
            "Creating nanobodies that can self-replicate in vivo."
        ],
        "What is one of the primary advantages of nanobodies over traditional antibodies in SARS-CoV-2 applications?": [
            "Their small size allows for better tissue penetration and recognition of cryptic epitopes.",
            "They have a higher molecular weight, making them more stable.",
            "They are derived from the variable domain of light-chain antibodies.",
            "They require complex mammalian cell systems for production."
        ],
        "Which technology is primarily used to identify antigen-specific nanobodies?": [
            "Phage display technology.",
            "CRISPR-Cas9 gene editing.",
            "Flow cytometry.",
            "Mass spectrometry."
        ]
    }
}